Results

Total Results: 564 records

Showing results for "past months".

61. EPC Methods: An Exploration of Methods and Context for the Production of Rapid Reviews (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
    February 01, 2015 - , but ranged from 1-3 months to 2-4 months (i.e., all had an upper limit of more than 2 months as distinct … 1 to 2 months. … Five of the 10 rapid response products limited search dates, usually to the past 5 years, and a couple … 2 to 4 months. … In some cases, a maximum number of studies were set and if the initial search went past the limit, the

62. Kidney-Stone-Prevention Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-stone-prevention_research-protocol.pdf
    June 15, 2011 - RCTs as short as 3 months in duration may be considered to address the KQs related to the adverse effects … chronic kidney disease, obesity, pregnancy, solitary kidney, urinary tract anatomic abnormality, past … oxalate, potassium, soft drinks); baseline stone characteristics (stone composition, frequency of past … stone episodes, severity of past stone episodes, past shock-wave lithotripsy, or presence of residual … The dispositions of the peer review comments will be documented and published three months after the

63. Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Final Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/outcome-research-white-paper.pdf
    June 01, 2022 - This section presents a graph of PHQ-9 scores from the past year. … reviews, research agendas, treatment guidelines, and prioritization research published within the past … Frequency over the past 2 weeks (once, several days, more than half the days, nearly every day) b. … Neither positive response nor negation Does not recognize that this is most likely indicating past … However, given the magnitude of the challenges facing health care professionals over the past year,

64. AHRQ Slide Template
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-pain-management-grand-rounds-slides.pptx
    March 01, 2022 - Noninvasive Nonpharmacologic Treatments for Chronic Pain 9 BACKGROUND Chronic pain: Pain lasting ≥ 3 months … or persisting past normal tissue healing time Leading cause of disability; impacts physical and mental … Pacific Northwest Evidence-based Practice Center Summary of Evidence on Harms Short-Term: 1 to <6 Months … Change in Overall Function: Comparable THC to CBD Ratio Versus Placebo Short-Term: 1 to <6 Months … Placebo Short-term: 1 to <6 months Living Review 28 Entering third year since initial review.

65. Noninvasive, Nonpharmacological Treatment for Chronic Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-treatment-pain_research-protocol-amended.pdf
    September 20, 2017 - and Burden of Chronic Pain Chronic pain, defined as pain lasting 12 weeks or longer or persisting past … Opioid prescriptions for chronic pain have increased substantially in the past 20 years, but evidence … Adults with the following chronic pain (defined as pain lasting 12 weeks or longer or pain persisting past … • Timing: o Duration of followup: short term (up to 6 months), intermediate term (6-12 months) … (KQ 6) KQ=Key Question *Chronic pain is defined as pain lasting ≥ 12 weeks or pain persisting past

66. Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
    June 01, 2017 - Seven of the records without results indicate studies with completion dates in the future or recent past … 2004 Finland26, 27 RCT Academic/Hospital Inclusion Criteria: at least 3 AOM episodes during the past … Paradise 2001 11309632 Early TT TT six months later if bilateral effusion persisted or nine months … completion dates in the future, and five indicated active status but have a completion date in the past … Seven of the records without results indicate studies with completion dates in the future or recent past

67. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update - Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/noninvasive-nonpharm-pain-summary.pdf
    April 01, 2020 - or longer or persisting past the normal time for tissue healing, though definitions vary.2,4 Chronic … ), intermediate term (≥6 to <12 months) and long term (≥12 months). … ), intermediate term (≥6 to <12 months) and long term (≥12 months). … ; Intermediate-Term: ≥6 to <12 months; Long-Term: ≥12 months Effect Size: none, small, moderate, or large … ; Intermediate-Term: ≥6 to <12 months; Long-Term: ≥12 months Effect Size: none, small, moderate, or large

68. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
    February 01, 2011 - Studies amassing over the past decade have led to a number of clinical and policy changes regarding

69. Psychological and Pharmacological Treatments for Adults with Posttraumatic (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
    December 31, 2017 - for PTSD within 1 month of trauma exposure, and 17.0 percent continue to meet criteria for PTSD 12 months … defined by evidence-based guidelines as receiving either appropriate pharmacotherapy for 2 or more months … The disposition of comments for systematic reviews and technical briefs will be published 3 months after … • Past week, past month, and worst month (lifetime) PTSD can be estimated. … • Interviewees are asked about symptoms they have experienced in the past 2 weeks.

70. Engaging-Caregivers-Appendix-B (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
    May 29, 2025 - Confirmed recent substance use during the baseline assessment (i.e., alcohol or other drug use in the past … better satisfaction) MICU: 87 vs. 90 CICU: 92 vs. 90 Referrals to post-ICU recovery clinic (mean; 4 months … post intervention vs. 4 months pre intervention) 8.8 per month vs. 5 referrals per month NR NR Support … Usual care (4 months directly preceding implementation period) (n=171) English; Spanish No - created … Duration: NR Followup: 4 month (post-intervention period during same months as preintervention period

71. Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
    December 31, 2022 - (range 4–13 months). … Median followup time was 8 months (range 4–13 months). … For this estimate, strength of evidence is low for 7-10 months and insufficient for >10 months. … Past history of B-cell NHL in remission, active surveillance or during first-line or second-line treatment … No past history of lymphoma.

72. Template for Draft Reports (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
    October 06, 2006 - AWESOME reported MI within the past 7 days for 35% and 32% among PCI and CABG arms, respectively RITA … months 0.327 0.013 8.215 0.497 49 / 50 50 / 50 RITA* Survival 6 months 1.000 0.301 3.325 1.000 501 / … 12 months -0.012 -0.034 0.010 0.278 511 / 532 491 / 505 EAST Survival 12 months -0.020 -0.059 0.019 … 24 months Survival 24 months Survival 24 months Survival 24 months Survival 24 months Survival 24 months … MI 36 months MI 36 months MI 36 months EAST E G -0.15 -0.08 0.00 0.08 0.15 Fav ors CABG Fav

73. Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic Review of Pharmacological Interventions (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
    December 05, 2018 - disorders during the perinatal period (immediately prior to pregnancy, during pregnancy, and through 12 months … The study compared the prevalence of mental health disorders in past-year pregnant women (pregnant at … the time of the survey or pregnant in the prior 12 months), postpartum women (a subset of past-year … pregnant women who were pregnant during the prior 12 months but not at the time of the interview), … The disposition of comments for systematic reviews and technical briefs will be published three months

74. S131 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
    October 01, 2007 - restricted our population of statin initiators to those who had not used a glaucoma medication in the past … were required to have evidence of one of the following risk factors as recorded in claims from the past … stroke, transitory ischemic attack, MI, arterial surgery, or amputation for vascular dis- ease in the past … , or atrial fibrillation in the past 6 months. … Finally, we eliminated subjects with evidence of dementia or cancer in the past year.

75. Evaluation of Dietary Protein Intake Requirements (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-protocol-amendment.pdf
    November 28, 2023 - Indicator AA oxidation method ● Mean protein intake of infants fed principally human milk (0-6 months … ) ● Mean protein content of human milk (0-6 months) Timing KQ1 & 2 ● All duration and follow up … We will stop screening citations remaining past a 95% recall rate of citations eligible for full-text … ) ● Mean protein content of human milk (0-6 months) ● Body composition (lean mass) ● Linear … )” and “mean AA intake of infants fed principally human milk (0-6 months)” was excluded in order

76. rheumatoid-arthritis-medicine-update-protocol-170515 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-update_research-protocol.pdf
    May 15, 2017 - The American College of Rheumatology (ACR) uses a duration of fewer than 6 months of symptoms of disease … However, data on disease-modifying antirheumatic drug (DMARD) use in the first 3 months are limited. … Methods challenges, moreover, remain the same as with past reviews. … study define as early RA, provided that it includes a disease diagnosis no more than 1 year in the past … Age and comorbidity burden have increased at first RA presentation prior to DMARD treatment over the past

77. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
    March 01, 2013 - be the predominant Continual leakage, post void residual urine volume >200 mL, uterine prolapse past … were treated within 2 weeks of screening visit with antimuscarinic agents, were treated within the past … leakage, elevated postvoid residual urine volume (4200 mL), narrow angle glaucoma, uterine prolapse past … predominant mixed incontinence, recurrent urinary tract infection (UTI; ≥3 episodes within the past … Inc. and Glaxo- Smithkline Wang, 200686 Age: 16 to 80 years; OAB for more than 6 months.

78. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - depending on expert comments received on interventions issued for comment during the preceding 6 months … More recently (in the past 12–15 months), even fewer topics have met criteria for tracking because

79. Evidence-Summary-CER-209-Noninvasive-Nonpharmacological-Treatment-For-Chronic-Pain (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-209-evidence-summary-non-pharma-chronic-pain.pdf
    June 01, 2018 - or longer or persisting past the normal time for tissue healing, though definitions vary.1,3 Chronic … ), intermediate term (≥6 to <12 months) and long term (≥12 months). … ), intermediate term (≥6 to <12 months) and long term (≥12 months). … ; Intermediate-Term: ≥6 to <12 months; Long-Term: ≥12 months Effect Size: none, slight/small, moderate … ; Intermediate-Term: ≥6 to <12 months; Long-Term: ≥12 months Effect Size: none, slight/small, moderate

80. Topic-Brief3-Sud (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief3-SUD.pdf
    April 01, 2021 - settings, and inpatient settings.12-14 Chronic pain, often defined as pain lasting longer than 3 to 6 months … , or past the time of normal tissue healing, has an estimated prevalence of 20.4 percent in U.S. adults … In 2019, there were an estimated 20.4 million Americans 12 years or older with past-year substance use … 6 months).15 In people 85 years of age and older, the prevalence of chronic pain was 33.6 percent and … Outcomes were assessed at 12 months.